Completed OBSERVATIONAL NCT02641964

Risk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis

Sponsor: Nanjing Medical University

Conditions Acute Necrotizing Pancreatitis Acute Respiratory Distress Syndrome

Updated 11 times since 2017 Last updated: Jan 22, 2021 Started: Nov 30, 2015 Primary completion: Jan 31, 2021 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02641964, this observational or N/A phase trial focuses on Acute Necrotizing Pancreatitis and Acute Respiratory Distress Syndrome and remains completed. Sponsored by Nanjing Medical University, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2021 — Jul 2024 [monthly]

Completed

Status: Suspended → Completed
Jan 2021 — Feb 2021 [monthly]

Suspended
Nov 2020 — Jan 2021 [monthly]

Suspended

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Suspended
May 2018 — Jun 2018 [monthly]

Suspended
Apr 2018 — May 2018 [monthly]

Suspended

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Suspended NA
Apr 2017 — Aug 2017 [monthly]

Suspended NA

Status: Enrolling By Invitation → Suspended
Jan 2017 — Apr 2017 [monthly]

Enrolling By Invitation NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing Medical University

Data source: Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.